Literature DB >> 30787221

[Impact of DVH Outliers Registered in Knowledge-based Planning on Volumetric Modulated Arc Therapy Treatment Planning for Prostate Cancer].

Tatsuya Kamima1, Minoru Yoshioka1, Ryo Takahashi2, Tomoharu Sato1.   

Abstract

RapidPlan, a knowledge-based planning software, uses a model library containing the dose-volume histogram (DVH) of previous treatment plans, and it automatically provides optimization objectives based on a trained model to future patients for volumetric modulated arc therapy treatment planning. However, it is unknown how DVH outliers registered in models influence the resulting plans. The purpose of this study was to investigate the effect of DVH outliers on the resulting quality of RapidPlan knowledge-based plans generated for patients with prostate cancer. First, 123 plans for patients with prostate cancer were used to populate the initial model (modelall). Next, modelall-20 and modelall-40 were created by excluding DVH outliers of bladder optimization contours 20 and 40 patients from modelall, respectively. These models were used to create plans for a 20-patient. The plans created using modelall-40 showed reductions of D30% and D50% in the bladder wall dose, and the DVH shape excluding outliers were affected. However, there were no significant differences in monitor units, target doses, or bladder wall doses between each treatment plan. Thus, we have shown that removal of DVH outliers from models does not affect the quality of plans created by the model.

Entities:  

Keywords:  RapidPlan; dose-volume histogram (DVH) outliers; knowledge-based planning; prostate cancer; volumetric modulated arc therapy

Mesh:

Year:  2019        PMID: 30787221     DOI: 10.6009/jjrt.2019_JSRT_75.2.151

Source DB:  PubMed          Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi        ISSN: 0369-4305


  1 in total

1.  Integration of automation into an existing clinical workflow to improve efficiency and reduce errors in the manual treatment planning process for total body irradiation (TBI).

Authors:  David H Thomas; Brian Miller; Rachel Rabinovitch; Sarah Milgrom; Brian Kavanagh; Quentin Diot; Moyed Miften; Leah K Schubert
Journal:  J Appl Clin Med Phys       Date:  2020-05-19       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.